C-MER Medical Holdings (03309) reported that its authorized share capital remained at 8,000,000,000 ordinary shares at a par value of HKD 0.1 each, totaling HKD 800,000,000. There was no change in the number of shares issued or held in treasury, with 1,212,780,870 issued shares (excluding treasury shares) and 19,562,000 treasury shares as of January 31, 2026.

The company confirmed that it continued to meet the required public float threshold of 25%. In addition, under its Post-IPO Share Option Scheme (exercise price at HKD 7.73), 133,334 share options remained outstanding at the end of January, with a total of 92,120,000 shares potentially issuable upon the full exercise of all share options. The filing also provided standard confirmations of compliance with listing rules and relevant regulatory requirements.